Antibodies are classified as the top class of therapeutics, due largely to their ability to connect with distinctive ligand conformations in an effort to elicit individual biological responses. On the other hand, discovery of new molecules binding unique epitopes is time intensive and complicated, especially for situations demanding a particular an